Key Points
- Myomo Director Heather Getz purchased 70,000 shares on March 12 at an average price of $0.73 (total ~$51,100), raising her ownership to 111,754 shares — a 167.65% increase.
- MYO trades around $0.70 with a market cap of about $27.1M and a 12‑month range of $0.64–$5.62, and while several hedge funds have recently increased positions, four analysts maintain an average Buy rating with a $7.67 price target.
Myomo, Inc. (NYSEAMERICAN:MYO - Get Free Report) Director Heather Getz bought 70,000 shares of the business's stock in a transaction on Thursday, March 12th. The stock was purchased at an average price of $0.73 per share, with a total value of $51,100.00. Following the completion of the transaction, the director directly owned 111,754 shares of the company's stock, valued at $81,580.42. This trade represents a 167.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.
Myomo Price Performance
NYSEAMERICAN MYO traded up $0.01 on Friday, reaching $0.70. 267,761 shares of the stock traded hands, compared to its average volume of 508,509. Myomo, Inc. has a 12 month low of $0.64 and a 12 month high of $5.62. The company has a market cap of $27.07 million, a price-to-earnings ratio of -1.90 and a beta of 1.17. The firm's fifty day simple moving average is $0.85 and its 200 day simple moving average is $0.92. The company has a quick ratio of 2.10, a current ratio of 3.30 and a debt-to-equity ratio of 0.98.
Hedge Funds Weigh In On Myomo
A number of hedge funds have recently modified their holdings of MYO. Cubist Systematic Strategies LLC lifted its holdings in shares of Myomo by 157.4% during the first quarter. Cubist Systematic Strategies LLC now owns 49,101 shares of the company's stock valued at $236,000 after purchasing an additional 30,028 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Myomo during the 1st quarter worth about $75,000. Jane Street Group LLC raised its holdings in Myomo by 84.2% during the 1st quarter. Jane Street Group LLC now owns 162,658 shares of the company's stock worth $782,000 after buying an additional 74,338 shares during the period. Acadian Asset Management LLC purchased a new stake in Myomo during the first quarter valued at about $114,000. Finally, Geode Capital Management LLC lifted its stake in Myomo by 160.8% during the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company's stock valued at $1,446,000 after buying an additional 412,631 shares in the last quarter. 44.99% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MYO has been the topic of a number of research analyst reports. Craig Hallum reaffirmed a "buy" rating on shares of Myomo in a report on Tuesday. Ascendiant Capital Markets reduced their price objective on shares of Myomo from $10.50 to $10.00 and set a "buy" rating for the company in a research report on Friday, November 21st. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Myomo presently has an average rating of "Buy" and an average price target of $7.67.
Check Out Our Latest Stock Analysis on MYO
About Myomo
(
Get Free Report)
Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company's flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users' own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.
Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
